About this webinar
Ever wondered what the future of cancer treatment looks
like? It’s here, and it’s called precision oncology. At its forefront is a groundbreaking spatial biology technology called Imaging Mass Cytometry™ (IMC™),
which allows Bernd Bodenmiller and his team to get a unique overview of the complexity of the tumor microenvironment.
Through the use of IMC, a cutting-edge method that involves using antibodies with unique isotopes to bind to targets in tissue samples without endogenous autofluorescence or image artifacts.
An extraordinary ability to measure transcripts and proteins simultaneously, and even generate 3D tumor models.
But it doesn’t stop there. This innovative technology provides a detailed overview of cellular type, location, interaction and morphology of tumors and is designed to help scientists understand the underlying causes of diseases to determine the most effective treatments.
This isn’t just theoretical research. It’s been put into practice in clinical trials, like the Tumor Profiler Study.
To provide personalized treatment recommendations based on molecular data. This approach has the potential to improve overall response rates and patient outcomes.
Chat and interact with us!
When you watch the recording, you will still be able to reach out to us with questions through the chat and participate in the experience as if it were live!